# Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support

> **NCT05286554** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 75 (actual)

## Conditions studied

- Female Infertility

## Interventions

- **DRUG:** gonadotropin releasing hormone-agonist
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT05286554
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-17
- **Primary completion:** 2023-10-27
- **Final completion:** 2024-01-18
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286554, "Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05286554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*